Literature DB >> 12746790

Contamination of bone marrow products with an actinomycete resembling Microbacterium species and reinfusion into autologous stem cell and bone marrow transplant recipients.

Zahir Hirji1, Ronnie Saragosa, Heln Dedier, Michael Crump, Norman Franke, Lori Burrows, Frances Jamieson, Shirley Brown, Michael A Gardam.   

Abstract

Bacterial contamination of bone marrow or peripheral blood stem cell transplant products typically occurs with skin flora or, rarely, gram-negative organisms. We describe a clonal outbreak of contamination in transplant products caused by contamination with an aerobic actinomycete that occurred at our institution during the summer of 2001. From 1 July through 12 September 2001, 73 peripheral blood or bone marrow stem cell products were obtained from 39 patients, and 34 products were found to be contaminated with the outbreak strain. Fourteen patients were reinfused with contaminated cells, and the outbreak strain was isolated from the blood cultures for one patient. Investigation revealed multiple potential sources for contamination during the product cryopreservation process. The outbreak of contamination was aborted upon modification of the cryopreservation process.

Entities:  

Mesh:

Year:  2003        PMID: 12746790     DOI: 10.1086/374051

Source DB:  PubMed          Journal:  Clin Infect Dis        ISSN: 1058-4838            Impact factor:   9.079


  2 in total

1.  Identities of Microbacterium spp. encountered in human clinical specimens.

Authors:  Kathrina Gneiding; Reinhard Frodl; Guido Funke
Journal:  J Clin Microbiol       Date:  2008-09-17       Impact factor: 5.948

2.  Phenotypic and genotypic properties of Microbacterium yannicii, a recently described multidrug resistant bacterium isolated from a lung transplanted patient with cystic fibrosis in France.

Authors:  Poonam Sharma; Seydina M Diene; Sandrine Thibeaut; Fadi Bittar; Véronique Roux; Carine Gomez; Martine Reynaud-Gaubert; Jean-Marc Rolain
Journal:  BMC Microbiol       Date:  2013-05-03       Impact factor: 3.605

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.